China Merchants CSI Vaccine and Biotechnology ETF (SHA:561920)

Assets	n/a
Expense Ratio	n/a
PE Ratio	31.03
Dividend (ttm)	n/a
Dividend Yield	n/a
Ex-Dividend Date	n/a
Payout Frequency	n/a
Payout Ratio	n/a
1-Year Return	-15.52%

Volume	5,694,000
Open	0.6730
Previous Close	0.6730
Day's Range	0.6700 - 0.6890
52-Week Low	0.5830
52-Week High	0.8150
Beta	0.42
Holdings	44
Inception Date	Mar 15, 2023

About 561920

561920.SS was created on 2023-03-15 by China Merchants. The fund's investment portfolio concentrates primarily on health care equity.

• Asset Class: Equity
• Category: Health Care
• Stock Exchange: Shanghai Stock Exchange
• Ticker Symbol: 561920
• Provider: China Merchants
• Index Tracked: CSI Vaccine and Biotechnology Index - CNY - Benchmark TR Gross

Performance

561920 had a total return of -15.52% in the past year, including dividends. Since the fund's inception, the average annual return has been -10.54%.

Top 10 Holdings

46.79% of assets

Name	Symbol	Weight
Walvax Biotechnology Co., Ltd.	300142	9.73%
Chongqing Zhifei Biological Products Co., Ltd.	300122	6.55%
Chengdu Olymvax Biopharmaceuticals Inc.	688319	5.83%
Liaoning Cheng Da Co., Ltd.	600739	4.33%
Sichuan Biokin Pharmaceutical Co.,Ltd.	688506	4.23%
RemeGen Co., Ltd.	688331	3.64%
Shenzhen Kangtai Biological Products Co., Ltd.	300601	3.56%
Shanghai Junshi Biosciences Co., Ltd.	688180	3.23%
Shanghai Fosun Pharmaceutical (Group) Co., Ltd.	600196	2.87%
Gan & Lee Pharmaceuticals.	603087	2.81%

Data Sources: S&P Global Market Intelligence and Finnhub

Historical data is provided by S&P Global Market Intelligence. Several fund data points are also provided by Finnhub.

Last checked:

Sep 23, 2026

Data Sources Report a data error